BLOCK IgE; UNLOCK LIFE in 3 indications
Omalizumab IN CSU: PREDICTORS AND DOSE SELECTION

Omalizumab IN CSU: PREDICTORS AND DOSE SELECTION

Severe allergic asthma 6 years of age and above

Speaker's slide: Lt.Col. Yiwa Suksawat: Severe allergic asthma 6 years of age and above

Omalizumab: Anti-IgE for Nasal Polyps

Omalizumab: Anti-IgE for Nasal Polyps

Rating: 
No votes yet
FA-11312659
×

Medical Information Request

×

Ask Speakers